FDA Warns Of Drug Pair's Muscle Injury Link

Law360, New York (August 11, 2008, 12:00 AM EDT) -- With cholesterol drug Vytorin already under fire, federal regulators are warning against combining one of the drug's main ingredients with a medication that monitors heart rhythm, contending that the mix can lead to a potentially fatal muscle injury.

On Friday, the FDA issued an alert to health care professionals warning of the dangerous effects of simultaneously taking amiodarone and doses of simvastatin higher than 20 milligrams a day.

“The FDA is notifying the public of the risk of a rare condition of muscle injury called rhabdomyolysis,...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.